Category Archives: Cancer and neoplasms
Sep
Introduction Cancer is the second leading cause of death worldwide, and the incidence continues annually. National cancer statistics show that in 2016, the number of new cancers in China was 4.064 million, and the number of deaths from cancer was 2.414 million. According to the latest global cancer burden data released by the World Health […]
Introduction: “Proton Beam Therapy Equipment Market” Insights Report 2023 | Spread Across 92 Pages Report which provides an in-depth analysis Based on Regions, Applications (Pediatric Neoplasms, Prostate Cancer, Others), and Types (Synchrotron, Cyclotron, Synchrocyclotron, Linear Accelerator). The report presents the research and analysis provided within the Proton Beam Therapy Equipment Market Research is meant to […]
Gastrointestinal Stromal Tumors Cells Rapidly Died Between 48 and 72 Hours After Exposure to HT-KIT. HT-KIT Shows Positive Results in AML Positive Preclinical Results of Novel HT-KIT Therapeutic Performed at NC State University NEW YORK, Sept. 13, 2023 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that HT-KIT, a new molecular entity, for the […]
Cancer and neoplasms
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
Sep
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update News Home Wednesday, September 13, 2023 03:00 AM | GlobeNewswire via QuoteMedia Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022. Updated clinical and preclinical data on […]
Cancer and neoplasms
Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out – MediciNova, Mesoblast, Veru, Pluristem, Avalo, Boehringer Ingelheim, Genentech, Windtree
Sep
New York, USA, Sept. 13, 2023 (GLOBE NEWSWIRE) — Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out – MediciNova, Mesoblast, Veru, Pluristem, Avalo, Boehringer Ingelheim, Genentech, Windtree The acute respiratory distress syndrome market size shall grow during the forecast period (2023–2032) owing to the […]
Sep
Citation Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni, Sabrina Croce, Isabelle Ray-Coquard, Fatma Valentina. Guermazi, Biagio Paolini, Félix Blanc-Durand, Axel Lecesne, Valentina Chiappa, Angelo Paolo. Dei Tos, Paolo Giovanni. Casali; Low-grade uterine Leiomyosarcoma is highly sensitive to hormonal treatment.. Clin Cancer Res 2023; https://doi.org/10.1158/1078-0432.CCR-23-0692 Download citation file: